Evidence map›Paper›PMID 23733878›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1.

Luke R Donius, Jennifer M Handy, Janis J Weis, John H Weis

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Divergent roles for complement components C3 and C4 in controllingbioRxiv : the preprint server for biology · 2025
    Article
  3. Review
  4. Frontiers in cellular and infection microbiology · 2022
    Review
  5. Review
  6. Review
  7. Article
  8. Secreted IgM: New tricks for an old molecule.Journal of leukocyte biology · 2019
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Luke R DoniusDivision of Cell Biology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Jennifer M Handy
Janis J Weis
John H Weis
University of Utah · US

Funding

BORRELIA BURGDORFERI MITOGEN IN DEVELOPMENT OF ARTHRITISR01AI032223 · NIAID · UNIVERSITY OF UTAH · PI WEIS, JANIS J. · 1993 to 2023
$7.8M
Training Program in Microbial PathogenesisT32AI055434 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A, PLANELLES, VICENTE · 2004 to 2025
$6.0M
REGULATION OF CR2/CD21 EXPRESSION AND ACTIVATIONR01AI024158 · NIAID · UNIVERSITY OF UTAH · PI WEIS, JOHN · 1987 to 2012
$3.5M
Salmonella Antimicrobial Peptide ResistanceR01AI043521 · NIAID · OHIO STATE UNIVERSITY · PI GUNN, JOHN S · 2004 to 2013
$3.1M
Role of Ifitm/Fragilis proteins as intracellular shuttles during cell activationR21AI088451 · NIAID · UNIVERSITY OF UTAH · PI WEIS, JOHN · 2011 to 2012
$413k
SALMONELLA ANTIMICROBIAL PEPTIDE RESISTANCER29AI043521 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI GUNN, JOHN S · 1998 to 2002
$409k
Borrelia Burgdorferi Mitogen in Development of ArthritisR56AI032223 · NIAID · UNIVERSITY OF UTAH · PI WEIS, JANIS J. · 2013 to 2013
$350k
NIAID NIH HHS 5T32-AI-055434NIAID NIH HHS AI-088451NIAID NIH HHS AI-24158NIAID NIH HHS AI-32223NIAID NIH HHS AI-43521NIAID NIH HHS R01 AI024158NIAID NIH HHS R01 AI032223NIAID NIH HHS R01 AI043521NIAID NIH HHS R21 AI088451NIAID NIH HHS R29 AI043521NIAID NIH HHS R56 AI032223NIAID NIH HHS T32 AI055434
6 · The paper itself

Abstract

Follicular dendritic cells (FDCs) and complement receptor (Cr)1 and complement receptor (Cr)2 are important for the generation of humoral immunity. Cr1/2 expression on B cells and FDCs was shown to provide a secondary signal for B cell activation, to facilitate transport of Ag in immune follicles, and to enhance retention of immune complexes by FDCs. We show in this study that murine B cells predominantly express the Cr2 product from the Cr2 gene, whereas FDCs almost exclusively express the Cr1 isoform generated from the Cr2 gene. To define the specific role of Cr1, we created an animal that maintains normal cell-restricted expression of Cr2 but does not express Cr1. Cr1-deficient (Cr1KO) mice develop normal B1 and B2 immature and mature B cell subsets and have normal levels of naive serum Abs but altered levels of natural Abs. Immunization of the Cr1KO animal demonstrates deficient Ab responses to T-dependent, but not T-independent, Ags. Germinal centers from the immunized Cr1KO animal possess a deficiency in activated B cells, similar to that seen for animals lacking both Cr1 and Cr2 or C3. Finally, animals lacking only Cr1 respond similarly to wild-type animals to infections with Streptococcus pneumoniae, a pathogen to which animals lacking C3 or both Cr1 and Cr2 are particularly sensitive. Altogether, these data suggest that the production of Cr1, primarily by FDCs, is critical in the generation of appropriately activated B cells of the germinal center and the generation of mature Ab responses.

Indexed as

AnimalsB-Lymphocyte SubsetsDendritic Cells, FollicularFemaleGene Expression RegulationGerminal CenterImmunoglobulin MLymphocyte ActivationMaleMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutProtein IsoformsReceptors, Complement 3bReceptors, Complement 3dImmunoglobulin MProtein IsoformsReceptors, Complement 3bReceptors, Complement 3d

Identifiers

PMID23733878
PMCPMC3707406
OpenAlexW2103979696

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.